These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 25446337

  • 21. A pharmacist-driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients.
    Wang N, Athans V, Neuner E, Bollinger J, Spinner M, Brizendine K.
    Transpl Infect Dis; 2018 Dec; 20(6):e12991. PubMed ID: 30184302
    [Abstract] [Full Text] [Related]

  • 22. Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis.
    Solidoro P, Patrucco F, Libertucci D, Verri G, Sidoti F, Curtoni A, Boffini M, Simonato E, Rinaldi M, Cavallo R, Costa C.
    Ther Adv Respir Dis; 2019 Dec; 13():1753466619878555. PubMed ID: 31566097
    [No Abstract] [Full Text] [Related]

  • 23. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C, Pérez-Romero P, Blanco-Lobo P, Benmarzouk-Hidalgo OJ, Sánchez M, Gentil MA, Bernal C, Sobrino JM, Rodríguez-Hernández MJ, Cordero E, Spanish Network for Research in Infectious Diseases (REIPI).
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [Abstract] [Full Text] [Related]

  • 24. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients.
    Grossi P, Minoli L, Percivalle E, Irish W, Vigano M, Gerna G.
    Transplantation; 1995 Mar 27; 59(6):847-51. PubMed ID: 7701579
    [Abstract] [Full Text] [Related]

  • 25. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.
    Rittà M, Costa C, Sidoti F, Ballocco C, Ranghino A, Messina M, Biancone L, Cavallo R.
    New Microbiol; 2015 Jul 27; 38(3):329-35. PubMed ID: 26147141
    [Abstract] [Full Text] [Related]

  • 26. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
    Moscarelli L, Caroti L, Antognoli G, Zanazzi M, Di Maria L, Carta P, Minetti E.
    Clin Transplant; 2013 Jul 27; 27(4):546-54. PubMed ID: 23758330
    [Abstract] [Full Text] [Related]

  • 27. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
    Demopoulos L, Polinsky M, Steele G, Mines D, Blum M, Caulfield M, Adamkovic A, Liu Q, Harler MB, Hahn C, Singh A.
    Transplant Proc; 2008 Jun 27; 40(5):1407-10. PubMed ID: 18589118
    [Abstract] [Full Text] [Related]

  • 28. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
    da Cunha-Bang C, Sørensen SS, Iversen M, Sengeløv H, Hillingsø JG, Rasmussen A, Mortensen SA, Fox ZV, Kirkby NS, Christiansen CB, Lundgren JD.
    Scand J Infect Dis; 2011 May 27; 43(5):360-5. PubMed ID: 21306196
    [Abstract] [Full Text] [Related]

  • 29. Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis.
    Hammond SP, Martin ST, Roberts K, Gabardi S, Fuhlbrigge AL, Camp PC, Goldberg HJ, Marty FM, Baden LR.
    Transpl Infect Dis; 2013 Apr 27; 15(2):163-70. PubMed ID: 23230972
    [Abstract] [Full Text] [Related]

  • 30. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM, Scott GM, Naing Z, Glanville AR, Rawlinson WD.
    Transpl Infect Dis; 2011 Apr 27; 13(2):145-53. PubMed ID: 21070537
    [Abstract] [Full Text] [Related]

  • 31. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
    Puchhammer-Stöckl E, Görzer I, Zoufaly A, Jaksch P, Bauer CC, Klepetko W, Popow-Kraupp T.
    Transplantation; 2006 Jan 27; 81(2):187-94. PubMed ID: 16436961
    [Abstract] [Full Text] [Related]

  • 32. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
    Ohata K, Chen-Yoshikawa TF, Takahashi K, Aoyama A, Motoyama H, Hijiya K, Hamaji M, Menju T, Sato T, Sonobe M, Takakura S, Date H.
    Interact Cardiovasc Thorac Surg; 2017 Nov 01; 25(5):710-715. PubMed ID: 29049752
    [Abstract] [Full Text] [Related]

  • 33. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP.
    Semin Respir Infect; 2002 Dec 01; 17(4):265-73. PubMed ID: 12497543
    [Abstract] [Full Text] [Related]

  • 34. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
    Varga M, Remport A, Czebe K, Péter A, Toronyi E, Sárváry E, Fehérvári I, Sulyok B, Járay J.
    Orv Hetil; 2008 Mar 23; 149(12):551-8. PubMed ID: 18343771
    [Abstract] [Full Text] [Related]

  • 35. Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation.
    Piñana JL, Perez-Pitarch A, Guglieri-Lopez B, Giménez E, Hernandez-Boluda JC, Terol MJ, Ferriols-Lisart R, Solano C, Navarro D.
    Am J Transplant; 2018 Dec 23; 18(12):2885-2894. PubMed ID: 29603596
    [Abstract] [Full Text] [Related]

  • 36. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.
    Santos CA, Brennan DC, Yusen RD, Olsen MA.
    Transplantation; 2015 Aug 23; 99(8):1658-66. PubMed ID: 25675196
    [Abstract] [Full Text] [Related]

  • 37. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 Aug 23; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 38. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA.
    Transpl Infect Dis; 2009 Jun 23; 11(3):195-202. PubMed ID: 19228345
    [Abstract] [Full Text] [Related]

  • 39. Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients.
    Danziger-Isakov LA, DelaMorena M, Hayashi RJ, Sweet S, Mendeloff E, Schootman M, Huddleston CB, DeBaun MR.
    Transplantation; 2003 May 15; 75(9):1538-43. PubMed ID: 12792511
    [Abstract] [Full Text] [Related]

  • 40. Cytomegaloviral infection in solid organ transplant recipients: preliminary report of one transplant center experience.
    Hryniewiecka E, Sołdacki D, Pączek L.
    Transplant Proc; 2014 Oct 15; 46(8):2572-5. PubMed ID: 25380868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.